Robin L. Washington
2016
In 2016, Robin L. Washington earned a total compensation of $5.1M as Executive Vice President and Chief Financial Officer at Gilead Sciences, a 9% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $938,485 |
|---|---|
| Option Awards | $1,599,971 |
| Salary | $900,385 |
| Stock Awards | $1,619,221 |
| Other | $10,000 |
| Total | $5,068,062 |
Washington received $1.6M in stock awards, accounting for 32% of the total pay in 2016.
Washington also received $938.5K in non-equity incentive plan, $1.6M in option awards, $900.4K in salary and $10K in other compensation.
Rankings
In 2016, Robin L. Washington's compensation ranked 1,584th out of 14,075 executives tracked by ExecPay. In other words, Washington earned more than 88.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,584 out of 14,075 | 89th |
Division Manufacturing | 538 out of 5,489 | 90th |
Major group Chemicals And Allied Products | 152 out of 1,895 | 92nd |
Industry group Drugs | 104 out of 1,538 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 20 out of 279 | 93rd |
Source: SEC filing on March 26, 2018.
Washington's colleagues
We found four more compensation records of executives who worked with Robin L. Washington at Gilead Sciences in 2016.